Literature DB >> 18625635

CD8+CD28-, suppressive T cells in systemic lupus erythematosus.

A Tulunay1, S Yavuz, H Direskeneli, E Eksioglu-Demiralp.   

Abstract

Recent studies show that a CD8+CD28- phenotype of T-cell population inhibits the reactivity of T-helper cells either by a contact-dependent mechanism or with secreting suppressive cytokines. In this study, we have explored the peripheral blood CD8+CD28- T-cell population in 53 patients with systemic lupus erythematosus (SLE) in comparison to healthy and diseased control groups. The distribution of CD28- cells within CD8+ population has been found significantly lower in patients with SLE than in healthy individuals. While there were no significant differences in the expression of costimulatory molecules CD80 and CD86, the CD40 expression on monocytes was found significantly lower and there was a slight decrease of expression of Interleukin-10 (IL-10) in CD8+CD28- population in patients with SLE. The Transforming growth factor-beta (TGF-beta) mRNA expression was found higher in CD8+CD28- T cells. Neither activation induced nor time-dependent change in the frequency of CD8+CD28- cells has been observed following stimulation at various time-points indicating that the control of CD28 expression was not dependent on the presence of sustained stimulations. Decrease in CD8+CD28- T cells which normally produce TGF-beta and their low-level IL-10 content may reflect impaired T-cell suppression and accordingly, increased T cell help to autoreactive B cells in patients with SLE.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18625635     DOI: 10.1177/0961203308089400

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  31 in total

1.  The expression of molecule CD28 and CD38 on CD4⁺/CD8⁺ T lymphocytes in thymus and spleen elicited by Schistosoma japonicum infection in mice model.

Authors:  Na Li; Peng-yu Ji; Lan-gui Song; Jun-xia Lei; Zhi-yue Lv; Zhong-dao Wu; Xiao Shao; Xi Sun
Journal:  Parasitol Res       Date:  2015-05-24       Impact factor: 2.289

Review 2.  CD8+ CD28- and CD8+ CD57+ T cells and their role in health and disease.

Authors:  Marius Strioga; Vita Pasukoniene; Dainius Characiejus
Journal:  Immunology       Date:  2011-06-29       Impact factor: 7.397

3.  Skin-Resident Effector Memory CD8+CD28- T Cells Exhibit a Profibrotic Phenotype in Patients with Systemic Sclerosis.

Authors:  Gang Li; Adriana T Larregina; Robyn T Domsic; Donna B Stolz; Thomas A Medsger; Robert Lafyatis; Patrizia Fuschiotti
Journal:  J Invest Dermatol       Date:  2016-12-22       Impact factor: 8.551

Review 4.  Recent advances in CD8+ regulatory T cell research.

Authors:  Yating Yu; Xinbo Ma; Rufei Gong; Jianmeng Zhu; Lihua Wei; Jinguang Yao
Journal:  Oncol Lett       Date:  2018-03-29       Impact factor: 2.967

Review 5.  CD8+ Tregs in lupus, autoimmunity, and beyond.

Authors:  Ravi K Dinesh; Brian J Skaggs; Antonio La Cava; Bevra H Hahn; Ram Pyare Singh
Journal:  Autoimmun Rev       Date:  2010-04-10       Impact factor: 9.754

6.  A peptide tetramer Tk-tPN induces tolerance of cardiac allografting by conversion of type 1 to type 2 immune responses via the Toll-like receptor 2 signal-promoted activation of the MCP1 gene.

Authors:  Zuoqing Li; Neng Yang; Ling Zhou; Peng Gu; Hui Wang; Yun Zhou; Peijun Zhou; Liming Lu; Kuang-Yen Chou
Journal:  Immunology       Date:  2016-03       Impact factor: 7.397

7.  T regulatory cells and Th1/Th2 cytokines in peripheral blood from tuberculosis patients.

Authors:  X-Y He; L Xiao; H-B Chen; J Hao; J Li; Y-J Wang; K He; Y Gao; B-Y Shi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-03-21       Impact factor: 3.267

Review 8.  CD28 negative T cells: is their loss our gain?

Authors:  D Mou; J Espinosa; D J Lo; A D Kirk
Journal:  Am J Transplant       Date:  2014-10-16       Impact factor: 8.086

9.  Altered levels of circulating CD8+CXCR5+PD-1+T follicular cytotoxic cells in primary Sjögren's syndrome.

Authors:  Xuwen Zhai; Yanlin Wang; Hui Guo; Zhaojun Liang; Min Feng; Yanyao Wu; Yan Qin; Xiangcong Zhao; Chong Gao; Jing Luo
Journal:  Clin Rheumatol       Date:  2022-02-16       Impact factor: 2.980

10.  Defective CD8+CD28+ regulatory T cell suppressor function in rheumatoid arthritis is restored by tumour necrosis factor inhibitor therapy.

Authors:  S Ceeraz; C Hall; E H Choy; J Spencer; V M Corrigall
Journal:  Clin Exp Immunol       Date:  2013-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.